Mexiletine hydrochloride

Mexiletine hydrochloride is a medication primarily used in the treatment of ventricular arrhythmias, such as ventricular tachycardia, a condition characterized by rapid heart rhythms originating from the lower chambers of the heart. It belongs to the class of drugs known as Class IB antiarrhythmic agents, which work by blocking sodium channels in the heart, thereby slowing the rate at which the heart's electrical impulses are conducted. This action helps to restore normal heart rhythm and maintain a regular heartbeat.

Medical Uses

Mexiletine hydrochloride is indicated for the management of documented ventricular arrhythmias, such as sustained ventricular tachycardia, that are life-threatening. It is often used when other treatments are not effective or cannot be tolerated. Additionally, it has been investigated for use in the treatment of chronic pain, especially in conditions like diabetic neuropathy, due to its sodium channel blocking properties, which are similar to those of lidocaine.

Mechanism of Action

As a Class IB antiarrhythmic agent, mexiletine hydrochloride works by blocking voltage-gated sodium channels in the cardiac cells. This blockade decreases the influx of sodium ions during the action potential, which in turn reduces the rate of depolarization and the duration of the action potential. This effect is particularly pronounced in cells with a high rate of firing, making mexiletine effective in treating arrhythmias without significantly affecting the heart rate or blood pressure in normal heart rhythms.

Pharmacokinetics

Mexiletine is well absorbed from the gastrointestinal tract, with peak plasma concentrations occurring 2 to 4 hours after oral administration. It is extensively metabolized in the liver, with its metabolites being excreted primarily in the urine. The half-life of mexiletine is approximately 10 to 20 hours, allowing for two to three times daily dosing to maintain therapeutic plasma levels.

Adverse Effects

Common side effects of mexiletine hydrochloride include nausea, vomiting, dizziness, tremor, and nervousness. More serious side effects can include cardiac arrhythmias, hepatic dysfunction, and blood dyscrasias. Due to its potential to cause adverse effects, careful monitoring of heart function and liver enzymes is recommended during treatment.

Contraindications

Mexiletine hydrochloride is contraindicated in patients with a history of cardiogenic shock, severe heart block (unless a pacemaker is in place), and those with a known hypersensitivity to the drug. Caution is advised in patients with pre-existing liver impairment or congestive heart failure.

Interactions

Mexiletine can interact with other medications, including other antiarrhythmic drugs, which can either potentiate or diminish its effects. It may also interact with phenytoin, theophylline, and cimetidine, among others, necessitating adjustments in dosing or careful monitoring.

Conclusion

Mexiletine hydrochloride is an important medication in the management of ventricular arrhythmias and has potential applications in the treatment of chronic pain conditions. Its use, however, requires careful consideration of its pharmacokinetics, potential adverse effects, and interactions with other medications to ensure safe and effective treatment.

‎